We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluation of Doxycyline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy (POC1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00511875
Recruitment Status : Completed
First Posted : August 6, 2007
Last Update Posted : October 8, 2012
Juvenile Diabetes Research Foundation
Information provided by (Responsible Party):
Thomas W. Gardner, Penn State University